Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Depreciation and Depletion: 2011-2024

Historic Depreciation and Depletion for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $663,000.

  • Niagen Bioscience's Depreciation and Depletion fell 4.27% to $157,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $624,000, marking a year-over-year decrease of 9.43%. This contributed to the annual value of $663,000 for FY2024, which is 23.79% down from last year.
  • Latest data reveals that Niagen Bioscience reported Depreciation and Depletion of $663,000 as of FY2024, which was down 23.79% from $870,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Depreciation and Depletion ranged from a high of $890,000 in FY2021 and a low of $663,000 during FY2024.
  • Moreover, its 3-year median value for Depreciation and Depletion was $869,000 (2022), whereas its average is $800,667.
  • Per our database at Business Quant, Niagen Bioscience's Depreciation and Depletion climbed by 14.30% in 2020 and then fell by 23.79% in 2024.
  • Over the past 5 years, Niagen Bioscience's Depreciation and Depletion (Yearly) stood at $871,000 in 2020, then grew by 2.18% to $890,000 in 2021, then dropped by 2.36% to $869,000 in 2022, then grew by 0.12% to $870,000 in 2023, then dropped by 23.79% to $663,000 in 2024.